{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fdc82df51-359b-46a0-bfa8-70ca48de0de5","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/dc82df51-359b-46a0-bfa8-70ca48de0de5\"></iframe>","title":"Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation","description":"\n        <p>Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have actionable activating mutations.</p>\n\n<p>CME information and select publications <a href=\"http://www.researchtopractice.com/OncologyTodayNSCLCwithoutActionableMutation22\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/071224fd-07e9-4b16-ab33-9ef77130f96a/cover.jpg"}